CenterBook Partners »

Arcutis Biotherapeutics shares owned by CenterBook Partners

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by CenterBook Partners from 13F filings

Historical chart of CenterBook Partners investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by CenterBook Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by CenterBook Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 61k 26.22

More positions owned by CenterBook Partners

Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Visa Com Cl A (V)
Texas Instruments Incorporated (TXN)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Netflix (NFLX)
Biontech Se Sponsored Ads (BNTX)

View all positions for CenterBook Partners

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Rubric Capital Management
Polar Capital Holdings
State Street Corporation
Vanguard Capital Management
Jennison Associates
Morgan Stanley
D. E. Shaw & Co
UBS Group
Bank of America Corporation
Geode Capital Management
Vanguard Portfolio Management
OrbiMed Advisors

View all funds holding Arcutis Biotherapeutics